Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01959958 · ClinicalTrials.gov registry record
Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 250
- Enrollment target
NCT01959958 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 250 participants.
The verdict
NCT01959958 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
Pediatric patients with sickle cell disease are at greater risk for exhibiting nocturnal enuresis (bedwetting) compared to the general population. This increased risk has been attributed to a decreased ability to concentrate urine caused by sickling-induced nephropathy. The sociodemographic, psychosocial, and medical factors associated with nocturnal enuresis are not well defined. In addition, the impact of these behaviors on emotional and behavioral functioning, along with health-related quality of life are not clear. Despite the availability of evidence-based interventions for nocturnal enuresis, very few families with a child with sickle cell disease have utilized these methods. The reasons for this underutilization of interventions are not clear.
Interventions
- OTHER Questionnaire/Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01959958
The ClinicalTrials.gov registry entry for NCT01959958 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire/Interview is the first listed.
NCT01959958 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01959958 about?
NCT01959958 is a clinical study titled "Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease". Pediatric patients with sickle cell disease are at greater risk for exhibiting nocturnal enuresis (bedwetting) compared to the general population. This increased risk has been attributed to a decreased ability to concentrate urine caused by sickling-induced nephropathy. The sociodemographic, psychos...
What is the current status of trial NCT01959958?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2013-10. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01959958?
The interventions under investigation include: Questionnaire/Interview (OTHER).
Who is sponsoring clinical trial NCT01959958?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.